Fresenius Kabi Files EU Pegfilgrastim

‘Milestone’ Biosimilar Submission Comes Ahead Of Planned Launch In 2021

 
• By David Wallace
  
Fresenius Kabi
Fresenius Kabi has seen its biosimilar pegfilgrastim filing accepted for EMA review • Source: Shutterstock

More from Biosimilars

More from Products